Mechanism of action and receptor profile
The pharmacodynamics of norepinephrine is based on its direct stimulating effect on adrenergic receptors. The drug has a high affinity for two main groups of receptors:
- Alpha-adrenergic receptors: there is a powerful stimulation of α1- and α2-adrenergic receptors located in blood vessels. This leads to generalized vasospasm.
- Beta-adrenergic receptors: the drug actively acts on myocardial β1-adrenergic receptors.
The key pharmacological feature that distinguishes it from epinephrine (adrenaline) is that norepinephrine has practically no effect on β2-adrenergic receptors. Precisely because of the lack of stimulation of vascular β2-receptors (which are responsible for vasodilation), there is no subsequent phase of blood pressure reduction following the administration of norepinephrine.
Effects on the cardiovascular system
The drug's hemodynamic effects develop rapidly, but are short-lived. The main clinical effect is a pronounced increase in blood pressure (BP) caused by vasoconstriction.
Despite its direct stimulating effect on cardiac β1-receptors (which increases myocardial contractility and stroke volume), cardiac output ultimately does not increase. This is due to a complex compensatory mechanism — reflex bradycardia:
- A sharp spike in blood pressure leads to mechanical stretching and excitation of baroreceptors located in the aortic arch.
- Afferent impulses reach the medulla oblongata, stimulating the vagus nerve center (n. vagus).
- The inhibitory influence of the parasympathetic system on the sinoatrial node of the myocardium is enhanced.
- There is a predictable decrease in heart rate (HR) that compensates for the increase in stroke volume.
Pharmacological test: this reflex response can be prevented. If the patient is pre-treated with atropine (an M-cholinergic receptor blocker), the vagus nerve influence is eliminated, and bradycardia does not develop.
Pharmacokinetics and administration guidelines
The drug molecule is extremely unstable in the body, which dictates strict rules for its use. Oral administration is absolutely ineffective because the active substance is rapidly destroyed in the gastrointestinal tract.
Intramuscular and subcutaneous administration is strictly not recommended (or contraindicated). Due to the powerful stimulation of alpha-receptors, a severe local vasospasm occurs at the injection site, leading to profound ischemia and subsequent tissue necrosis.
The only appropriate route of administration is intravenous. With a single injection, the effect lasts only a few minutes. Such rapid inactivation is explained by two factors: active reuptake of the substance by adrenergic nerve endings and enzymatic degradation (via monoamine oxidase — MAO, and catechol-O-methyltransferase — COMT). To maintain a stable therapeutic effect, the drug is administered via continuous intravenous infusion. Excretion of metabolites and a minor fraction of the unchanged substance is carried out by the kidneys.
Clinical profile: indications and risks
The only strict indication for prescribing norepinephrine is conditions accompanied by an acute, life-threatening drop in blood pressure (acute hypotension).
Side effects include:
- Headache (due to sharp changes in cerebral vascular tone and increased BP);
- Cardiac arrhythmias;
- Respiratory disorders.
Contraindications to use are quite extensive. The drug should not be used in severe atherosclerosis, heart failure, and atrioventricular block. Interaction with anesthetics requires special attention: norepinephrine is contraindicated during halothane (fluorothane) anesthesia. Halothane causes myocardial sensitization to catecholamines, and administering norepinephrine against this background carries an extremely high risk of fatal arrhythmias.
Briefly: answers to topical questions
In which types of shock is norepinephrine the first-line vasopressor?
Norepinephrine is the drug of choice in cardiogenic shock to correct hemodynamic instability and maintain perfusion during hypotension. In septic shock, norepinephrine is prescribed when fluid resuscitation at 30 ml/kg fails to achieve a mean arterial pressure greater than 65 mmHg. In distributive and obstructive shock, norepinephrine can be used as part of vasopressor support.
What side effects can occur with the use of norepinephrine?
When using norepinephrine (Norepinephrinum), systemic and local side effects may occur. The main adverse reactions include:
- Respiratory disorders
- Headache
- Cardiac arrhythmias (including reflex bradycardia due to a sharp increase in blood pressure).
In addition, upon accidental subcutaneous or intramuscular administration, the drug causes severe vasospasm at the injection site, ultimately leading to necrosis of the surrounding tissues.
What are the contraindications for the use of norepinephrine?
There are the following contraindications to the use of norepinephrine (Norepinephrinum):
- Heart failure
- Severe atherosclerosis
- Atrioventricular block
- Halothane (fluorothane) anesthesia — the combination is prohibited due to the high risk of arrhythmias resulting from myocardial sensitization to catecholamines.
Furthermore, subcutaneous and intramuscular administration of the drug is strictly not recommended due to the high risk of tissue necrosis at the injection site.
How does norepinephrine affect total peripheral vascular resistance (TPVR)?
Norepinephrine causes vasoconstriction by stimulating α-receptors. The cited sources do not explicitly state the effect of norepinephrine on TPVR. Conversely, upon α1-adrenergic receptor blockade or norepinephrine depletion, a decrease in TPVR is observed.
Norepinephrine "forgets" about beta-two: it powerfully constricts vessels (alpha receptors) and raises blood pressure, but does not cause a secondary pressure drop phase because vascular β2 receptors are not activated by it.
Class and exam questions
What is the main hemodynamic difference between norepinephrine and epinephrine?
Norepinephrine lacks a secondary blood pressure drop phase because it does not stimulate vascular β2-adrenergic receptors responsible for vasodilation.
Why does heart rate drop upon drug administration if it stimulates the heart?
This is reflex bradycardia. A sharp spike in blood pressure excites aortic baroreceptors, activates the vagus nerve, and its inhibitory effect on the heart overrides the drug's direct stimulating effect on β1 receptors.
What else to study on this topic
- Biochemical mechanisms of catecholamine inactivation by MAO and COMT enzymes
- Physiology of the aortic arch baroreceptor reflex
- Myocardial sensitization by halogenated anesthetics (fluorothane)
- Comparative profile of adrenaline and noradrenaline
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Norepinephrine» and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs Acting on Adrenergic Synapses"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.